Mission statement

Gatos Silver Provides Bi-weekly Status Report

Retrieved on:

Friday, November 11, 2022

Gatos Silver, Inc. (NYSE/TSX: GATO) (Gatos Silver or the Company) is providing this bi-weekly default status report in accordance with National Policy 12-203 - Management Cease Trade Orders (NP 12-203).

Key Points:

Gatos Silver, Inc. (NYSE/TSX: GATO) (Gatos Silver or the Company) is providing this bi-weekly default status report in accordance with National Policy 12-203 - Management Cease Trade Orders (NP 12-203).
Pursuant to NP 12-203, the Company must file bi-weekly status reports in the form of further news releases during the period from the Notice until the MCTO is revoked.
Gatos Silver is a silver dominant exploration, development and production company that discovered a new silver and zinc-rich mineral district in southern Chihuahua State, Mexico.
As a 70% owner of the Los Gatos Joint Venture (LGJV), the Company is primarily focused on operating the mine and mineral processing plant at the LGJVs Cerro Los Gatos deposit.

EQS-News: Deutsche Beteiligungs AG: Sale of investment in Cloudflight

Retrieved on:

Friday, November 11, 2022

Deutsche Beteiligungs AG (DBAG) has very successfully concluded its investment in Cloudflight, a leading european full-service provider for digital transformation, selling its stake to Partners Group, a leading global private markets firm, acting on behalf of its clients.

Key Points:

Deutsche Beteiligungs AG (DBAG) has very successfully concluded its investment in Cloudflight, a leading european full-service provider for digital transformation, selling its stake to Partners Group, a leading global private markets firm, acting on behalf of its clients.
Through its investment in Cloudflight, DBAG FundVII had structured smooth succession arrangements for the founder-led business.
The sale of the Cloudflight investment is the second disposal of a management buyout (MBO) from DBAGFundVIIs portfolio.
Deutsche Beteiligungs AG (DBAG) has been listed since 1985 and is one of most renowned private equity firms in Germany.

InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY

Retrieved on:

Friday, November 11, 2022

NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 11, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) today announced record preliminary financial results for the Third quarter of 2022. All amounts are expressed in Canadian dollars ($) or New Israeli Shekels (NIS), unless otherwise noted.

Key Points:

(NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the Company) today announced record preliminary financial results for the Third quarter of 2022.
Revenue growth expected to continue in Q4 2022.
Continued expansion of the company's branded products portfolio, launching more than 10 new GMP SKUs during the quarter.
The Company plans to file its full financial results for the third quarter on Tuesday, November 15th , 2022.

Ceres Acquisition Corp. Reports Third Quarter 2022 Financial Results

Retrieved on:

Friday, November 11, 2022

Ceres, SEDAR, Mission statement, Failure, FOR, GLOBE, Risk, Acquisition, Corporation, NEO, NOT, LLC, Legislation, COVID-19, System, Sponsor, Risk management, Financial services

TORONTO, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Ceres Acquisition Corp. (NEO: CERE.U, CERE.WT; OTCQX: CERAF) (“Ceres” or the “Corporation”) is reporting its financial results as at September 30, 2022 and September 30, 2021, and for the three and nine month periods then ended. The Corporation’s unaudited financial statements, along with the accompanying management’s discussion and analysis, have been filed on the System for Electronic Document Analysis and Retrieval (SEDAR) and may be viewed by interested parties under the Corporation’s profile at www.sedar.com.

Key Points:

NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR OTHER DISSEMINATION IN THE UNITED STATES
TORONTO, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Ceres Acquisition Corp. (NEO: CERE.U, CERE.WT; OTCQX: CERAF) (Ceres or the Corporation) is reporting its financial results as at September 30, 2022 and September 30, 2021, and for the three and nine month periods then ended.
Ceres is continuing to explore potential targets for a qualifying transaction.
About Ceres Group Acquisition Sponsor, LLC (the Sponsor)
The Sponsor is a limited liability company formed under the laws of Nevada.
This press release may contain forwardlooking information within the meaning of applicable securities legislation and includes statements which reflect Ceres and the Sponsors current expectations regarding future events.

High Arctic Announces 2022 Third Quarter Financial and Operating Results

Retrieved on:

Friday, November 11, 2022

CALGARY, Alberta, Nov. 11, 2022 (GLOBE NEWSWIRE) -- High Arctic Energy Services Inc. (TSX: HWO) (the “Corporation” or “High Arctic”) released its third quarter results today.

Key Points:

ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW
CALGARY, Alberta, Nov. 11, 2022 (GLOBE NEWSWIRE) -- High Arctic Energy Services Inc. (TSX: HWO) (the Corporation or High Arctic) released its third quarter results today.
High Arctic maintained a strong financial position, with working capital of $65,434 including $23,386 cash, $12,101 accounts receivable, $28,000 asset sale receivable (due in January 2023), and total debt of $7,860 as at September 30, 2022.
As reported last quarter, On July 27, 2022, High Arctic executed two separate asset sales transactions resulting in the effective divestment of the Corporations Production Services segment.
The unaudited interim consolidated financial statements, management discussion & analysis (MD&A), for the quarter ended September 30, 2022 will be available on SEDAR at www.sedar.com , and on High Arctics website at www.haes.ca .

Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update

Retrieved on:

Friday, November 11, 2022

RESEARCH TRIANGLE PARK, N.C., Nov. 11, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company focused on the development of PEDMARK® (sodium thiosulfate injection) to reduce the risk of ototoxicity associated with cisplatin in pediatric patients one month of age and older with localized, non-metastatic solid tumors today reported its financial results for the fiscal quarter ended September 30, 2022 and provided a business update.

Key Points:

This was an important quarter for Fennec with the FDA approval of PEDMARK and the successful buildout of our commercial infrastructure leading to the recent U.S. commercial launch of PEDMARK.
In addition, we successfully completed a $25 million financing, which we believe well positions the Company for the launch of PEDMARK, said Rosty Raykov, chief executive officer of Fennec Pharmaceuticals.
PEDMARK provides the first and only FDA-approved treatment specifically designed to help protect hearing in children and young adults after receiving cisplatin.
The complete unaudited condensed consolidated financial statements for the period ended September 30, 2022 and management's discussion and analysis of financial condition and results of operations will be available via www.sec.gov and www.sedar.com.All values are presented in thousands unless otherwise noted.

BTCS Reports Q3 2022 Results

Retrieved on:

Friday, November 11, 2022

Silver Spring, MD, Nov. 11, 2022 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (BTCS or the Company), a blockchain technology-focused company, announced results for the third quarter ending September 30, 2022.

Key Points:

Silver Spring, MD, Nov. 11, 2022 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (BTCS or the Company), a blockchain technology-focused company, announced results for the third quarter ending September 30, 2022.
However, revenue decreased by 33% from the second quarter of 2022 to $0.3 million for the third quarter of 2022.
Digital Asset impairment charges during Q3 2022 quarter amounted to $145,000 compared to $8.9 million in Q2 2022 and $3.3 million in Q1 2022, highlighting the impact of the crypto markets decline throughout the year on our financial statements.
The fair value of BTCSs Digital Assets rebounded 24% from June 30, 2022, to $14.8 million as of September 30, 2022.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Schmitt Industries, Inc. (SMIT)

Retrieved on:

Friday, November 11, 2022

GPM, Mission statement, Schmitt, NASDAQ, Suite, GLOBE, SMIT, Defendant, Court, News, Time

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points:

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
On this news, Schmitts stock fell $0.68, or 17.9%, to close at $3.12 per share on September 21, 2022, thereby injuring investors.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
Glancy Prongay & Murray LLP, Los Angeles

Element Announces Renewal and TSX Approval of Normal Course Issuer Bid

Retrieved on:

Friday, November 11, 2022

TORONTO, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Element Fleet Management Corp. (TSX: EFN) (“Element” or the “Company”) announced today that the Toronto Stock Exchange (the “TSX”) has approved the Company’s notice of intention to renew its normal course issuer bid (the “NCIB”) for its issued and outstanding common shares (the “Common Shares”) in furtherance of its capital return strategy.

Key Points:

As of November 1, 2022, the Company had 393,055,672 Common Shares issued and outstanding and a public float of 392,287,191 Common Shares.
The Company believes that the NCIB is in the best interests of the Company and constitutes a desirable use of its funds.
Under the current NCIB, the Company has repurchased Common Shares over the TSX and over alternative trading systems in Canada.
The ASPP has been approved by the TSX and will be entered into effective as of or about November 11, 2022.

BCS, YSG & OLO Class Action Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate

Retrieved on:

Friday, November 11, 2022

Complaint, Mission statement, Company, IPO, GLOBE, Defendant, SEC, Court, LLC, Security (finance), Barclays, Subway

NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.

Key Points:

NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.
You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.